Decoding the Structure–Property–Function Relationships in Covalent Organic Frameworks for Sustainable Battery Design حسب Tarek M. Madkour (4921354)

الموضوعات:

Comparing detector performance against increasing signal to noise ratios. حسب Bernd Porr (32394)

SBP3 KD decreases cytoadhesion of iRBCs to bovine brain endothelial cells (BBECs). حسب Atefeh Fathi (7370876)

Loss of <i>Rab23</i> decreases ciliation in MEFs and Tbr1 + intermediate progenitors. حسب Wan Ying Leong (22075947)

<i>Elsholtzia ciliata</i> extract (ECE) treatment decreases coronavirus-induced plaque formation. حسب Siyun Lee (17087351)

"…<b>(B)</b> ECE treatment decreases plaque formation in a dose-dependent manner. …"

VP16 protein abundance is decreased at low MOI in the ΔCTRL2 recombinant virus. حسب Pankaj Singh (116938)

EDLIoT: A method for decreasing energy consumption and latency using scheduling algorithm in Internet of Things حسب Arash GhorbanniaDelavar (22563696)

The relative importance by dominance analysis. حسب Lijuan Zhao (1387689)

الموضوعات:

Summary results of the samples. حسب Lijuan Zhao (1387689)

الموضوعات:

Description of digital inclusion. حسب Lijuan Zhao (1387689)

الموضوعات:

CSS data for this study. حسب Lijuan Zhao (1387689)

الموضوعات:

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and type-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. حسب Ayana Ablayeva (22103708)

الموضوعات:

Association between socio-demographic and medical parameters and all-cause mortality rates of liver cancer between 2014 and 2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and stage-specific incidence rate of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and age-specific mortality to incidence ratios of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Crude and residence-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Age- and sex- specific median yearly incidence (A) and mortality (B) rate of liver cancer per 10⁶ population over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات: